These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia. Helfand BT, Anderson CB, Fought A, Kim DY, Vyas A, McVary KT. Urology; 2009 Jul; 74(1):177-83. PubMed ID: 19428074 [Abstract] [Full Text] [Related]
4. Clinical relevance of transurethral resection of the prostate in "asymptomatic" patients with an elevated prostate-specific antigen level. van Renterghem K, Van Koeveringe G, Achten R, Van Kerrebroeck P. Eur Urol; 2007 Sep; 52(3):819-26. PubMed ID: 17418482 [Abstract] [Full Text] [Related]
5. Does transurethral resection of prostate (TURP) affect outcome in patients who subsequently develop prostate cancer? D'Ambrosio DJ, Ruth K, Horwitz EM, Chen DY, Pollack A, Buyyounouski MK. Urology; 2008 May; 71(5):938-41. PubMed ID: 18279939 [Abstract] [Full Text] [Related]
9. Are age-specific reference ranges for prostate specific antigen population specific? Wolff JM, Brehmer B, Borchers H, Rohde D, Jakse G. Anticancer Res; 2000 May; 20(6D):4981-3. PubMed ID: 11326652 [Abstract] [Full Text] [Related]
10. Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical management. Aydin H, Zhang J, Samaratunga H, Tan N, Magi-Galluzzi C, Klein E, Jones JS, Zhou M. BJU Int; 2010 Feb; 105(4):476-80. PubMed ID: 19709071 [Abstract] [Full Text] [Related]
11. Changes in serum prostate-specific antigen level after prostatectomy in patients with benign prostatic hyperplasia. Hosseini SY, Salimi M, Hosseini Moghaddam SM. Urol J; 2005 Feb; 2(4):183-8. PubMed ID: 17602426 [Abstract] [Full Text] [Related]
12. Importance of TURP in diagnosing prostate cancer in men with multiple negative biopsies. Philip J, Dutta Roy S, Scally J, Foster CS, Javlé P. Prostate; 2005 Jul 01; 64(2):200-2. PubMed ID: 15712218 [Abstract] [Full Text] [Related]
14. Probability of finding T1a and T1b (incidental) prostate cancer during TURP has decreased in the PSA era. Jones JS, Follis HW, Johnson JR. Prostate Cancer Prostatic Dis; 2009 Jul 01; 12(1):57-60. PubMed ID: 18379587 [Abstract] [Full Text] [Related]
15. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features. Vargas C, Kestin LL, Weed DW, Krauss D, Vicini FA, Martinez AA. Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):714-24. PubMed ID: 15708249 [Abstract] [Full Text] [Related]
17. Incidence and factors predicting the detection of prostate cancer after transurethral resection of the prostate for clinically benign disease. Bright EA, Manuel C, Goddard JC, Khan MA. Urol Int; 2009 Mar 01; 83(2):171-4. PubMed ID: 19752612 [Abstract] [Full Text] [Related]
20. Prospective study of the role of transurethral resection of the prostate in patients with an elevated prostate-specific antigen level, minor lower urinary tract symptoms, and proven bladder outlet obstruction. van Renterghem K, Van Koeveringe G, Achten R, van Kerrebroeck P. Eur Urol; 2008 Dec 01; 54(6):1385-92. PubMed ID: 18599187 [Abstract] [Full Text] [Related] Page: [Next] [New Search]